CN104116741A - Vilazodone hydrochloride composition and preparation method thereof - Google Patents
Vilazodone hydrochloride composition and preparation method thereof Download PDFInfo
- Publication number
- CN104116741A CN104116741A CN201310146602.3A CN201310146602A CN104116741A CN 104116741 A CN104116741 A CN 104116741A CN 201310146602 A CN201310146602 A CN 201310146602A CN 104116741 A CN104116741 A CN 104116741A
- Authority
- CN
- China
- Prior art keywords
- vilazodone hydrochloride
- microcarrier
- preparation
- surfactant
- vilazodone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310146602.3A CN104116741B (en) | 2013-04-24 | 2013-04-24 | Vilazodone Hydrochloride composition and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310146602.3A CN104116741B (en) | 2013-04-24 | 2013-04-24 | Vilazodone Hydrochloride composition and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104116741A true CN104116741A (en) | 2014-10-29 |
CN104116741B CN104116741B (en) | 2019-06-11 |
Family
ID=51762522
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310146602.3A Active CN104116741B (en) | 2013-04-24 | 2013-04-24 | Vilazodone Hydrochloride composition and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104116741B (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105125512A (en) * | 2015-09-09 | 2015-12-09 | 山东大学 | Crystal V-type puerarin tablets and preparation method thereof |
CN106667939A (en) * | 2017-02-14 | 2017-05-17 | 万全万特制药(厦门)有限公司 | Orally disintegrating tablet containing vilazodone hydrochloride and preparation method thereof |
WO2018082557A1 (en) * | 2016-11-02 | 2018-05-11 | Sunshine Lake Pharma Co., Ltd. | Vilazodone inclusion complexes, compositions and preparation thereof |
WO2020119698A1 (en) * | 2018-12-13 | 2020-06-18 | 广东东阳光药业有限公司 | Vilazodone solid dispersion and preparation method therefor |
CN111346097A (en) * | 2018-12-22 | 2020-06-30 | 江苏先声药业有限公司 | Composition and preparation method thereof |
CN114652671A (en) * | 2020-12-23 | 2022-06-24 | 上海博志研新药物技术有限公司 | Vilazodone pharmaceutical composition, preparation method and application thereof |
WO2023098745A1 (en) * | 2021-11-30 | 2023-06-08 | 广东东阳光药业有限公司 | Vilazodone composition, pharmaceutical preparation thereof, preparation therefor, and use thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102249979A (en) * | 2011-07-12 | 2011-11-23 | 上海开义医药化工有限公司 | Method for preparing 3-(4-chlorobutyryl)-1H-indole-5-methylcyanogen |
CN102267985A (en) * | 2011-06-15 | 2011-12-07 | 上海医药工业研究院 | Preparation method for vilazodone and hydrochloride thereof |
CN102949364A (en) * | 2011-08-30 | 2013-03-06 | 天津药物研究院 | Sustained release tablet containing effective component hydrochloric acid vilazodone |
-
2013
- 2013-04-24 CN CN201310146602.3A patent/CN104116741B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102267985A (en) * | 2011-06-15 | 2011-12-07 | 上海医药工业研究院 | Preparation method for vilazodone and hydrochloride thereof |
CN102249979A (en) * | 2011-07-12 | 2011-11-23 | 上海开义医药化工有限公司 | Method for preparing 3-(4-chlorobutyryl)-1H-indole-5-methylcyanogen |
CN102949364A (en) * | 2011-08-30 | 2013-03-06 | 天津药物研究院 | Sustained release tablet containing effective component hydrochloric acid vilazodone |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105125512B (en) * | 2015-09-09 | 2018-04-17 | 山东大学 | A kind of crystalline substance V-type Puerarin tablet and preparation method thereof |
CN105125512A (en) * | 2015-09-09 | 2015-12-09 | 山东大学 | Crystal V-type puerarin tablets and preparation method thereof |
US10688090B2 (en) | 2016-11-02 | 2020-06-23 | Sunshine Lake Pharma Co., Ltd. | Vilazodone inclusion complexes, compositions and preparation thereof |
WO2018082557A1 (en) * | 2016-11-02 | 2018-05-11 | Sunshine Lake Pharma Co., Ltd. | Vilazodone inclusion complexes, compositions and preparation thereof |
CN109922807A (en) * | 2016-11-02 | 2019-06-21 | 广东东阳光药业有限公司 | Vilazodone inclusion compound and combinations thereof and preparation method |
US11517569B2 (en) | 2016-11-02 | 2022-12-06 | Sunshine Lake Pharma Co., Ltd. | Vilazodone inclusion complexes, compositions and preparation thereof |
CN106667939A (en) * | 2017-02-14 | 2017-05-17 | 万全万特制药(厦门)有限公司 | Orally disintegrating tablet containing vilazodone hydrochloride and preparation method thereof |
WO2020119698A1 (en) * | 2018-12-13 | 2020-06-18 | 广东东阳光药业有限公司 | Vilazodone solid dispersion and preparation method therefor |
CN113164473A (en) * | 2018-12-13 | 2021-07-23 | 广东东阳光药业有限公司 | Vilazodone solid dispersion and preparation method thereof |
CN113164394A (en) * | 2018-12-13 | 2021-07-23 | 广东东阳光药业有限公司 | Vilazodone solid dispersion and preparation method thereof |
CN113164394B (en) * | 2018-12-13 | 2023-06-23 | 广东东阳光药业有限公司 | Vilazodone solid dispersion and preparation method thereof |
CN111346097A (en) * | 2018-12-22 | 2020-06-30 | 江苏先声药业有限公司 | Composition and preparation method thereof |
CN114652671A (en) * | 2020-12-23 | 2022-06-24 | 上海博志研新药物技术有限公司 | Vilazodone pharmaceutical composition, preparation method and application thereof |
WO2022135343A1 (en) * | 2020-12-23 | 2022-06-30 | 上海博志研新药物技术有限公司 | Vilazodone pharmaceutical composition, preparation method therefor and use thereof |
WO2023098745A1 (en) * | 2021-11-30 | 2023-06-08 | 广东东阳光药业有限公司 | Vilazodone composition, pharmaceutical preparation thereof, preparation therefor, and use thereof |
Also Published As
Publication number | Publication date |
---|---|
CN104116741B (en) | 2019-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104116741A (en) | Vilazodone hydrochloride composition and preparation method thereof | |
US7514552B2 (en) | Cellulose powder | |
CN105246598B (en) | Abiraterone acetate ester formulation | |
JP6086798B2 (en) | Tablet manufacturing method | |
CN101129346B (en) | Ambroxol hydrochloride oral cavity disintegrating tablet and method of producing the same | |
TWI572360B (en) | Tiny cellulose powder | |
CN106687112A (en) | Abiraterone acetate formulation and methods of use | |
JP7332549B2 (en) | How to suppress mount occurrence | |
CN102202691B (en) | Lactose and cellulose-based tableting aid | |
CN103356616A (en) | Bilastine-containing pharmaceutical composition and preparation method thereof | |
WO2004004692A1 (en) | Processes for the preparation of oral dosage formulations of modafinil | |
CN102292075A (en) | Pharmaceutical compositions with superior product performance and patient compliance | |
CN106999600A (en) | Include the disintegrating particles composition for crushing lactose or lactose of pelletizing | |
CN106551946A (en) | It is a kind of containing trifluorothymidine and hydrochloric acid for the pharmaceutical composition and preparation method than pyrimidine | |
CN108420798A (en) | A kind of immediate release drug formulations of anti-coagulants and preparation method thereof | |
JP6104038B2 (en) | Composite composition of crystalline cellulose | |
CN106540266A (en) | A kind of vilazodone pharmaceutical composition and preparation method thereof | |
CN112741819B (en) | Fluoxetine hydrochloride capsule and preparation method thereof | |
TW200824711A (en) | Embedded micellar nanoparticles | |
AU2013347264B2 (en) | Dispersible tablet | |
JP2019112358A (en) | Cellulose including compact for suppressing separation segregation | |
CN104352463A (en) | Ampicillin sodium dispersible tablet | |
CN111214442B (en) | Apixaban co-micropowder | |
CN104248769A (en) | Lurasidone pharmaceutical composition and preparation method thereof | |
CN113599360B (en) | Lurasidone hydrochloride self-emulsifying solid preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160707 Address after: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18 Applicant after: Jiangsu Simcere Pharmaceutical Co., Ltd. Address before: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18 Applicant before: Jiangsu Simcere Pharmaceutical Research Company Limited Applicant before: Jiangsu Simcere Pharmaceutical Co., Ltd. |
|
CB03 | Change of inventor or designer information |
Inventor after: Ji Yuanxin Inventor after: Li Ling Inventor after: Ren Jinsheng Inventor after: Wang Qingsong Inventor after: Liu Chunhui Inventor after: Xu Xiangyang Inventor before: Ji Yuanxin Inventor before: Li Ling Inventor before: Wang Qingsong Inventor before: Liu Chunhui Inventor before: Xu Xiangyang |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |